Researchers found that ArfGAP2 appears to play a key role in both normal immune responses and harmful overactivity.

New therapeutic "cocktails" could offer long-lasting relief for treatment-resistant asthma and other inflammatory diseases of ...

The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...

The companies reported Wednesday that batoclimab showed improvements in myasthenia gravis patients in a Phase 3 trial.

Type 1, not type 2 diabetes, is autoimmune. There are other rarer autoimmune types. Learn about type 2 diabetes, immunity, ...

SEOUL, March 13 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical firm, said Thursday it has launched its ...

Scientists have uncovered a critical piece of the puzzle in autoimmune diseases: a protein that helps release immune response ...

What if treating autoimmune diseases was as simple as regulating the acidity levels of parts of patients' cells? Genetic ...

As one of the brightest emerging biotechnology companies, Climb Bio Inc. (NASDAQ: CLYM) aims to improve the efficacy of autoimmune disease treatment. With its recently acquired lead asset ...

Now, researchers from Yale have found that a specific bacterium, called Enterococcus gallinarum, can move from the gut to ...

Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...

Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219 SYX-5219 is a ...